{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T16:02:12Z","timestamp":1776960132329,"version":"3.51.4"},"reference-count":71,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540293828","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/3-540-36583-4_11","type":"book-chapter","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T14:34:18Z","timestamp":1158676458000},"page":"195-220","source":"Crossref","is-referenced-by-count":15,"title":["Mass Vaccination Campaigns for Polio Eradication: An Essential Strategy for Success"],"prefix":"10.1007","author":[{"given":"R. W.","family":"Sutter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"11_CR1","first-page":"651","volume-title":"Poliovirus vaccine-live","author":"R.W. Sutter","year":"2003","unstructured":"Sutter RW, Kew OM, Cochi SL (2003) Poliovirus vaccine-live. In: Plotkin SA, Orenstein WA (eds), 4th edn. Vaccines. W.B. Saunders Company, Philadelphia, 25:651\u2013705.","edition":"4th edn."},{"key":"11_CR2","first-page":"2","volume":"82","author":"J. Majiyagbe","year":"2004","unstructured":"Majiyagbe J (2004) The volunteers\u2019 contribution to polio eradication. Bull WHO 82:2","journal-title":"Bull WHO"},{"key":"11_CR3","series-title":"WHA resolution","volume-title":"Polio eradication by the year 2000. Resolutions of the 41th World Health Assembly","author":"World Health Assembly","year":"1988","unstructured":"World Health Assembly (1988) Polio eradication by the year 2000. Resolutions of the 41th World Health Assembly. Geneva: World Health Organization, 1988 (WHA resolution no. 41.28)"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(94)92472-4","volume":"343","author":"H. Hull","year":"1994","unstructured":"Hull H, Ward NA, Hull B, Milstien JB, de Quadros C (1994) Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 343:1331\u20131337","journal-title":"Lancet"},{"key":"11_CR5","volume-title":"Patenting the Sun. Polio and the Salk Vaccine","author":"J. Smith","year":"1990","unstructured":"Smith J (1990) Patenting the Sun. Polio and the Salk Vaccine. William Morrow & Company, New York"},{"key":"11_CR6","first-page":"79","volume":"25","author":"M.P. Chumakov","year":"1961","unstructured":"Chumakov MP, Voroshilova MK, Drozdov SG, et al. (1961) Some results of the work on mass immunization in the Soviet Union with live poliovirus vaccine prepared from Sabin strains. Bull WHO 25:79\u201391","journal-title":"Bull WHO"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/biol.1993.1091","volume":"21","author":"V.I. Agol","year":"1993","unstructured":"Agol VI, Drozdov SG (1993) Russian contribution to OPV. Biologicals 21:321\u2013325","journal-title":"Biologicals"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/151.3.420","volume":"151","author":"A.B. Sabin","year":"1985","unstructured":"Sabin AB (1985) Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis 151:420\u2013436","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"11_CR9","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.1093\/clinids\/6.Supplement_2.S391","volume":"6","author":"A.B. Sabin","year":"1984","unstructured":"Sabin AB (1984) Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine. Rev Infect Dis 6(Suppl 2):S391\u2013S396","journal-title":"Rev Infect Dis"},{"key":"11_CR10","first-page":"179","volume":"53","author":"H.E. Robertson","year":"1962","unstructured":"Robertson HE, Acker MS, Dillenberg HO, et al. (1962) Community-wide use of a \u201cbalanced\u201d trivalent oral poliovirus vaccine (Sabin): a report of the 1961 trial at Prince Albert, Saskatchewan. Can Public Health J 53:179\u2013191","journal-title":"Can Public Health J"},{"key":"11_CR11","unstructured":"CDC. Poliomyelitis Prevention in the United States (1997) Introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 46(RR-3)"},{"key":"11_CR12","unstructured":"CDC (2000) Poliomyelitis Prevention in the United States. Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 49(RR-5)"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/bmj.1.6067.1012","volume":"i","author":"S. Ofusu-Amahh","year":"1977","unstructured":"Ofusu-Amahh S, Kratzer JH, Nicholas DD (1977) Is poliomyelitis a serious problem in developing countries?-lameness in Ghanaian schools. Brit Med J i:1012\u20131014","journal-title":"Brit Med J"},{"issue":"Suppl.2","key":"11_CR14","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1093\/clinids\/6.Supplement_2.S371","volume":"6","author":"R.H. Bernier","year":"1984","unstructured":"Bernier RH (1984) Some observations on poliomyelitis lameness surveys. Rev Infect Dis 6(Suppl.2):S371\u2013S375","journal-title":"Rev Infect Dis"},{"issue":"Suppl.2","key":"11_CR15","doi-asserted-by":"crossref","first-page":"S408","DOI":"10.1093\/clinids\/6.Supplement_2.S408","volume":"6","author":"R.R. Cruz","year":"1984","unstructured":"Cruz RR (1984) Cuba:mass polio vaccination program, 1962\u20131982. Rev Infect Dis 6(Suppl.2):S408\u2013S412","journal-title":"Rev Infect Dis"},{"key":"11_CR16","first-page":"221","volume":"72","author":"P. Mas Lago","year":"1994","unstructured":"Mas Lago P, Ramon Bravo J, Andrus JK, Comellas MM, Galindo MA, de Quadros CA, Bell E (1994) Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Bull WHO 72:221\u2013225","journal-title":"Bull WHO"},{"key":"11_CR17","first-page":"681","volume":"77","author":"P. Mas Lago","year":"1999","unstructured":"Mas Lago P (1999) Eradication of poliomyelitis in Cuba: a historical perspective. Bull WHO 77:681\u2013687","journal-title":"Bull WHO"},{"issue":"Suppl.2","key":"11_CR18","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1093\/clinids\/6.Supplement_2.S475","volume":"6","author":"R.H. Henderson","year":"1984","unstructured":"Henderson RH (1984) The Expanded Programme on Immunization of the World Health Organization. Rev Infect Dis 6(Suppl.2):S475\u2013S479","journal-title":"Rev Infect Dis"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/101053959100500209","volume":"5","author":"J.P. Grant","year":"1991","unstructured":"Grant JP (1991) Reaching the unreached: a miracle in the making. Asia Pac J Public Health 5:154\u2013162","journal-title":"Asia Pac J Public Health"},{"key":"11_CR20","first-page":"663","volume":"72","author":"C. Murray","year":"1994","unstructured":"Murray C, Kreuser J, Whang W (1994) Cost-effectiveness analysis and policy choices: investing in health systems. Bull WHO 72:663\u2013674","journal-title":"Bull WHO"},{"key":"11_CR21","volume-title":"WHO vaccine-preventable diseases: Monitoring system","author":"Vaccine and Biologicals Department","year":"2003","unstructured":"Vaccine and Biologicals Department (2003) WHO vaccine-preventable diseases: Monitoring system. 2003 global summary. Geneva: World Health Organization, (WHO\/V&B\/03.20)"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/oxfordjournals.aje.a115009","volume":"128","author":"A.M. McBean","year":"1988","unstructured":"McBean AM, Thoms ML, Albrecht P, et al. (1988) Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccine. Am J Epidemiol 128:615\u2013628","journal-title":"Am J Epidemiol"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/162.6.1291","volume":"162","author":"H. Faden","year":"1990","unstructured":"Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL (1990). Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis 162:1291\u20131297","journal-title":"J Infect Dis"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","volume":"13","author":"P.A. Patriarca","year":"1991","unstructured":"Patriarca PA, Wright PF, John TJ (1991) Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 13:926\u2013939","journal-title":"Rev Infect Dis"},{"key":"11_CR25","first-page":"333","volume":"51","author":"I. Dom\u00f6k","year":"1974","unstructured":"Dom\u00f6k I, Balayan MS, Fayinka OA, Skrtic N, Soneji AD, Harland PS (1974) Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda. Bull WHO 51:333\u2013347","journal-title":"Bull WHO"},{"key":"11_CR26","first-page":"5","volume":"64","author":"Expanded Program on Immunization","year":"1989","unstructured":"Expanded Program on Immunization (1989) Global Advisory Group (1988). Wkly Epidemiol Rec 64:5\u201310","journal-title":"Wkly Epidemiol Rec"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1006\/viro.1995.1420","volume":"211","author":"G.V. Rezapkin","year":"1995","unstructured":"Rezapkin GV, Norwood LP, Taffs RE, et al. (1995) Microevaluation of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Virology 211:377\u2013384","journal-title":"Virology"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0264-410X(92)90396-2","volume":"10","author":"N. Nathanson","year":"1992","unstructured":"Nathanson N, Horn SD (1992) Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964\u20131988. Vaccine 10:469\u2013474","journal-title":"Vaccine"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0140-6736(88)91229-9","volume":"i","author":"P.A. Patriarca","year":"1988","unstructured":"Patriarca PA, Laender F, Palmeira G, et al. (1988) Randomized trial of alternative formulations of orla poliovaccine in Brazil. Lancet i:429\u2013433","journal-title":"Lancet"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-3-7091-9278-8_25","volume-title":"Measles and poliomyelitis-vaccines and immunization","author":"P.A. Patriarca","year":"1993","unstructured":"Patriarca PA, Linkins RW, Sutter RW, Orenstein WA (1993) Optimal schedule for the administration of oral poliovirus vaccine. In Kurstak E (ed). Measles and poliomyelitis-vaccines and immunization. Springer, New York, Chapter 24 pp 303\u2013313"},{"issue":"Suppl.1","key":"11_CR31","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1093\/infdis\/175.Supplement_1.S247","volume":"175","author":"J.B. Milstien","year":"1997","unstructured":"Milstien JB, Lemon SM, Wright PF (1997) Development of a more thermostable poliovirus vaccine. J Infect Dis 175(Suppl.1):S247\u2013S253","journal-title":"J Infect Dis"},{"key":"11_CR32","first-page":"7","volume":"1","author":"Anonymous","year":"1996","unstructured":"Anonymous (1996) Vaccine vial monitors take guesswork out of immunization. Vaccine Immun News 1:7\u20138","journal-title":"Vaccine Immun News"},{"key":"11_CR33","first-page":"495","volume":"65","author":"D.L. Heymann","year":"1987","unstructured":"Heymann DL, Murphy K, Brigaud M, et al. (1987) Oral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates. Bull WHO 65:495\u2013501","journal-title":"Bull WHO"},{"issue":"Suppl.1","key":"11_CR34","first-page":"S189","volume":"175","author":"J.-M. Oliv\u00e9","year":"1977","unstructured":"Oliv\u00e9 J-M, Risi JB Jr, de Quadros CA (1977) National immunization days: Experience in Latin America. J Infect Dis 175(Suppl.1):S189\u2013S193","journal-title":"J Infect Dis"},{"issue":"Suppl.1","key":"11_CR35","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1093\/infdis\/175.Supplement_1.S194","volume":"175","author":"J. Bilous","year":"1997","unstructured":"Bilous J, Maher C, Tangermann RH, Aylward RB, et al. (1997) The experience of countries in the Western Pacific Region in conducting national immunization days for polio eradication. J Infect Dis 175(Suppl.1):S194\u2013S197","journal-title":"J Infect Dis"},{"key":"11_CR36","first-page":"330","volume":"78","author":"R.H. Tangermann","year":"2000","unstructured":"Tangermann RH; Hull HF, Jafari H, Nkowane B, Everts H, Aylward BR (2000) Eradication of poliomyelitis in countries affected by conflict. Bull WHO 78:330\u2013338","journal-title":"Bull WHO"},{"key":"11_CR37","first-page":"633","volume":"48","author":"CDC","year":"1999","unstructured":"CDC (1999) Progress toward poliomyelitis eradication during armed conflict-Somalia and Southern Sudan, January 1998\u2013June 1999. MMWR Morb Mortal Wkly Rep 48:633\u2013637","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/oxfordjournals.aje.a120717","volume":"86","author":"M. Benyesh-Melnick","year":"1967","unstructured":"Benyesh-Melnick M, Melnick JL, Rawls WE, et al. (1967) Studies on the immongenicity, communicability, and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol 86:112\u2013136","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"11_CR39","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1093\/clinids\/6.Supplement_2.S400","volume":"6","author":"J.B. Risi","year":"1984","unstructured":"Risi JB (1984) The control of poliomyelitis in Brazil. Rev Infect Dis 6(Suppl 2):S400\u2013S403","journal-title":"Rev Infect Dis"},{"key":"11_CR40","first-page":"835","volume":"65","author":"A.R. Hinman","year":"1987","unstructured":"Hinman AR, Foege WH, de Quadros CA, Patriarca PA, Orenstein WA, Brink EW (1987) The case for global eradication of poliomyelitis. Bull WHO 65:835\u2013840","journal-title":"Bull WHO"},{"issue":"Suppl.1","key":"11_CR41","first-page":"S183","volume":"175","author":"M.E. Birmingham","year":"1977","unstructured":"Birmingham ME, Aylward BR, Cochi SL, Hull HF (1977) National immunization days: State of the art. J Infect Dis 175(Suppl.1):S183\u2013S188","journal-title":"J Infect Dis"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/oxfordjournals.aje.a120717","volume":"86","author":"M. Benyesh-Melnick","year":"1967","unstructured":"Benyesh-Melnick M, Melnick JL, Rawls WE, et al. (1967) Studies on the immongenicity, communicability, and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol 86:112\u2013136","journal-title":"Am J Epidemiol"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/jama.275.21.1639","volume":"275","author":"R.T. Chen","year":"1996","unstructured":"Chen RT, Hausinger S, Dajani AS, et al. (1996) Seroprevalence of antibody against poliovirus in innercity preschool children: implications for vaccination policy in the United States. JAMA 275:1639\u20131645","journal-title":"JAMA"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00006454-199412000-00009","volume":"13","author":"M.E. Ramsey","year":"1994","unstructured":"Ramsey ME, Begg NT, Ghandi J, Brown D (1994) Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines. Pediatr Infect Dis J 13:1117\u20131121","journal-title":"Pediatr Infect Dis J"},{"key":"11_CR45","first-page":"769","volume":"73","author":"G. Richardson","year":"1995","unstructured":"Richardson G, Linkins RW, Eames MA, Wood DJ, Minor PD, Patriarca PA (1995) Immunogenicity of oral polio vaccine administered in mass campaigns versus routine immunization programs. Bull WHO 73:769\u2013777","journal-title":"Bull WHO"},{"issue":"Suppl.1","key":"11_CR46","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1093\/infdis\/175.Supplement_1.S215","volume":"175","author":"WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines","year":"1997","unstructured":"WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines (1997) Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman, and Thailand. J Infect Dis 175(Suppl.1):S215\u2013S227","journal-title":"J Infect Dis"},{"issue":"Suppl.1","key":"11_CR47","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1093\/infdis\/175.Supplement_1.S198","volume":"175","author":"M.R. Reichler","year":"1997","unstructured":"Reichler MR, Kharabshah S, Rhodes P, Otoum H, BLoch S, Majid MA, et al. (1997) Increased immunogenicity of oral poliovirus vaccine administered inmass vaccination campaigns compared with the routine vaccination programin Jordan. J Infect Dis 175(Suppl.1):S198\u2013S204","journal-title":"J Infect Dis"},{"issue":"Suppl.1","key":"11_CR48","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1093\/infdis\/175.Supplement_1.S254","volume":"175","author":"M.S. Deming","year":"1997","unstructured":"Deming MS, Linkins RW, Jaiteh KO, Hull HF (1997) The clinical efficacy of trivalent oral polio vaccine in The Gambia by season of vaccine administration. J Infect Dis 175(Suppl.1):S254\u2013S257","journal-title":"J Infect Dis"},{"issue":"Suppl.1","key":"11_CR49","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/175.Supplement_1.S258","volume":"175","author":"D.L. Posey","year":"1997","unstructured":"Posey DL, Linkins RW, Couto Oliveira MJ, Monteiro D, Patriarca PA (1997) The effect of diarrea on oral poliovirus vaccine failure in Brazil. J Infect Dis 175(Suppl.1):S258\u2013S263","journal-title":"J Infect Dis"},{"key":"11_CR50","volume-title":"The Association of Cases of Poliomyelitis with the Use of Type 3 Oral Poliomyelitis Vaccines","author":"L. Terry","year":"1962","unstructured":"Terry L (1962) The Association of Cases of Poliomyelitis with the Use of Type 3 Oral Poliomyelitis Vaccines. US Department of Health, Education and Welfare, Washington DC"},{"key":"11_CR51","first-page":"161","volume":"190","author":"Anonymous","year":"1964","unstructured":"Anonymous (1964) Oral poliomyelitis vaccine. Report of the Special Advisory Committee on Oral Poliomyelitis Vaccines to the Surgeon General of the Public Health Service. JAMA 190:161\u2013163","journal-title":"JAMA"},{"key":"11_CR52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1964.03070140047006","volume":"190","author":"D.A. Henderson","year":"1964","unstructured":"Henderson DA, Witte JJ, Morris L, Langmuir AD (1964) Paralytic disease associated with oral polio vaccines. JAMA 190:41\u201348","journal-title":"JAMA"},{"key":"11_CR53","first-page":"33","volume":"73","author":"J.A. Andrus","year":"1995","unstructured":"Andrus JA, Strebel PM, de Quadros CA, Olive JM (1995) Risk of vaccine-associated paralytic poliomyelitis in the America, 1989\u20131991. Bull WHO 73:33\u201340","journal-title":"Bull WHO"},{"key":"11_CR54","first-page":"210","volume":"80","author":"K.A. Kohler","year":"2002","unstructured":"Kohler KA, Banerjee K, Hlady WG, Andrus JK, Sutter RW (2002) Vaccineassociated paralytic poliomyelitis in India, 1999: decreased risk despite massive use of oral polio vaccine. Bull WHO 80:210\u2013216","journal-title":"Bull WHO"},{"key":"11_CR55","first-page":"987","volume":"80","author":"K.A. Kohler","year":"2002","unstructured":"Kohler KA, Banerjee K, Sutter RW (2002) Further clarity on vaccine-associated paralytic polio in India (letter). Bull WHO 80:987","journal-title":"Bull WHO"},{"key":"11_CR56","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/oxfordjournals.aje.a112290","volume":"104","author":"L.B. Schonberger","year":"1976","unstructured":"Schonberger LB, McGowan JE Jr, Gregg MB (1976) Vaccine-associated poliomyelitis in the United States, 1961\u20131972. Am J Epidemiol 104:202\u2013211","journal-title":"Am J Epidemiol"},{"key":"11_CR57","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jama.257.10.1335","volume":"257","author":"B.M. Nkowane","year":"1987","unstructured":"Nkowane BM, Wassilak SGF, Orenstein WA, et al. (1987) Vaccine-associated paralytic poliomyelitis: United States, 1973 through 1984. JAMA 257:1335\u20131340","journal-title":"JAMA"},{"key":"11_CR58","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","volume":"14","author":"P.M. Strebel","year":"1992","unstructured":"Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, Pallansch MA, Orenstein WA, Hinman AR (1992) Epidemiology of poliomyelitis in the United States:One decade after the last reported case of indigenouswild virus-associated disease. Clin Infect Dis 14:568\u2013579","journal-title":"Clin Infect Dis"},{"key":"11_CR59","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","volume":"292","author":"L.N. Alexander","year":"2004","unstructured":"Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, Sutter RW (2004) Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA 292:1696\u20131701","journal-title":"JAMA"},{"issue":"426","key":"11_CR60","first-page":"429","volume":"11","author":"R.W. Sutter","year":"1994","unstructured":"Sutter RW, Prevots DR (1994) Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med 11:426,429\u2013430, 435\u2013438","journal-title":"Infect Med"},{"key":"11_CR61","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00006454-199103000-00011","volume":"10","author":"C.A. Quadros de","year":"1991","unstructured":"de Quadros CA, Andrus JK, Olive J-M, Da Silveira CM, Eikhof RM, Carrasco P, Fitzsimmons JW, Pinheiro FP (1991) Eradication of poliomyelitis: progress in the Americas. Pediatr Infect Dis J 10:222\u2013229","journal-title":"Pediatr Infect Dis J"},{"key":"11_CR62","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1056\/NEJM199112193252504","volume":"325","author":"P.F. Wright","year":"1992","unstructured":"Wright PF, Kim-Farley RJ, de Quadros CA, Robertson SE, Scott RM, Ward NA, Henderson RH (1992) Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 325:1774\u20131779","journal-title":"N Engl J Med"},{"issue":"Suppl.1","key":"11_CR63","first-page":"S189","volume":"175","author":"J.-M. Oliv\u00e9","year":"1977","unstructured":"Oliv\u00e9 J-M, Risi JB Jr, de Quadros CA (1977) National immunization days: Experience in Latin America. J Infect Dis 175(Suppl.1):S189\u2013S193","journal-title":"J Infect Dis"},{"issue":"Suppl.1","key":"11_CR64","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1093\/infdis\/175.Supplement_1.S194","volume":"175","author":"J. Bilous","year":"1997","unstructured":"Bilous J, Maher C, Tangermann RH, Aylward RB, et al. (1997) The experience of countries in the Western Pacific Region in conducting national immunization days for polio eradication. J Infect Dis 175(Suppl.1):S194\u2013S197","journal-title":"J Infect Dis"},{"key":"11_CR65","volume-title":"Expanded Program on Immunization. Field Guide for Supplementary Activities Aimed at Achieving Polio Eradication","author":"WHO","year":"1996","unstructured":"WHO (1996) Expanded Program on Immunization. Field Guide for Supplementary Activities Aimed at Achieving Polio Eradication. World Health Organization, Geneva (WHO document WHO\/EPI\/GEN\/95.01 REV.1)"},{"key":"11_CR66","first-page":"213","volume":"19","author":"Pan American Health Organization","year":"1985","unstructured":"Pan American Health Organization (1985) Director announces campaign to eradicate poliomyelitis from the Americas by 1990. Bull Pan American Health Org 19:213\u2013215","journal-title":"Bull Pan American Health Org"},{"key":"11_CR67","first-page":"720","volume":"43","author":"CDC","year":"1994","unstructured":"CDC (1994) Certification of polio eradication-the Americas, 1994. MMWRMorb Mortal Wkly Rep 43:720\u2013722","journal-title":"MMWRMorb Mortal Wkly Rep"},{"key":"11_CR68","first-page":"1","volume":"50","author":"CDC","year":"2001","unstructured":"CDC (2001) Certification of polio eradication-Western Pacific Region, 2000. MMWR Morbid Mortal Wkly Rep 50:1\u20133","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"11_CR69","first-page":"221","volume":"77","author":"WHO","year":"2002","unstructured":"WHO (2002) Certification of poliomyelitis eradication, European Region, June 2002. Wkly Epidemiol Rec 77:221\u2013223","journal-title":"Wkly Epidemiol Rec"},{"key":"11_CR70","first-page":"349","volume":"79","author":"WHO","year":"2004","unstructured":"WHO (2004) Progress towards global poliomyelitis eradication: preparation for the oral poliovirus vaccine cessation era. Wkly Epidemiol Rec 79:349\u2013355","journal-title":"Wkly Epidemiol Rec"},{"key":"11_CR71","first-page":"401","volume":"79","author":"WHO","year":"2004","unstructured":"WHO (2004) Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21\u201322 September 2004. Wkly Epidemiol Rec 79:401\u2013407","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Current Topics in Microbiology and Immunology","Mass Vaccination: Global Aspects \u2014 Progress and Obstacles"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-36583-4_11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T21:03:32Z","timestamp":1619557412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-36583-4_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9783540293828"],"references-count":71,"URL":"https:\/\/doi.org\/10.1007\/3-540-36583-4_11","relation":{},"subject":[]}}